Works matching IS 10781552 AND DT 2022 AND VI 28 AND IP 5

Results: 40

The efficacy and safety of alpelisib in breast cancer: A real-world analysis.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1152, doi. 10.1177/10781552221096413

By:

Miller, Jenn;
Armgardt, Emily;
Svoboda, Alison

Publication type:

Article

Antineoplastic extravasation management: Consensus of the Spanish Oncology Pharmacy Group (GEDEFO).

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1170, doi. 10.1177/10781552221091914

By:

Albert-Marí, Asunción;
Jiménez-Pulido, Inmaculada;
José-Ruiz, Begoña San;
Conde-Estévez, David;
Gil-Lemus, Mª Ángeles;
Cercós-Lletí, Ana Cristina;
Esteban-Mensua, Mª Jesús;
Díaz-Carrasco, Mª Sacramento

Publication type:

Article

Case reports of acquired thrombotic thrombocytopenic purpura attributed to pembrolizumab.

Published in:

2022

By:

Gilbar, Peter J;
Dickey, Marcus SR

Publication type:

Letter to the Editor

Real-world incidence of venetoclax toxicities in British Columbia.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1163, doi. 10.1177/10781552221084616

By:

Lee, Cassandra;
Markarian, Adeline;
Ladha, Fatima;
Nakashima, Lynne;
de Lemos, Mario;
Schaff, Kimberly;
Woo, Stephanie;
Gerrie, Alina

Publication type:

Article

Impact of electronic interventions on guideline concordant ordering of rituximab infusion rate.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1157, doi. 10.1177/10781552221080722

By:

Moser, Katherine A;
Knoebel, Randall W;
Roth, Connor;
Parsad, Sandeep;
Schlei, Zachary

Publication type:

Article

Rasburicase induced methemoglobinemia: A systematic review of descriptive studies.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1189, doi. 10.1177/10781552221075239

By:

Vidhyashree, BH;
Zuber, Mohammed;
Taj, Shifa;
Venkataraman, Rajesh;
Sathish Kumar, BP;
Jabeen, Nihala

Publication type:

Article

Preservation of cognitive function after brain irradiation.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1182, doi. 10.1177/10781552221077037

By:

Surendran, Haripriya Parapparambil;
Narmadha, M P;
Kalavagunta, Sruthi;
Sasidharan, Ajay;
Dutta, Debnarayan

Publication type:

Article

Desensitization to Brentuximab Vedotin after anaphylaxis in refractory Hodgkin's lymphoma.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1264, doi. 10.1177/10781552221074965

By:

Villarreal-González, Rosalaura V;
González-Díaz, Sandra N;
Santos-Fernández, Wendy J;
Colunga-Pedraza, Perla R;
Varela-Constantino, Ana Laura;
Gómez-Almaguer, David

Publication type:

Article

Cecal volvulus associated with carfilzomib use for al amyloidosis.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1230, doi. 10.1177/10781552221074719

By:

Tuler, Shahaf;
Kaur, Jaspreet;
Dasanu, Constantin A.

Publication type:

Article

Hepatitis B reactivation after oral capecitabine treatment in a rectum cancer patient with isolated anti-HBc IgG positivity.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1283, doi. 10.1177/10781552221074627

By:

Tozlu, Mukaddes;
Toka, Bilal;
Eminler, Ahmet Tarik;
Karacaer, Cengiz;
Hacibekiroglu, Ilhan;
Uslan, Mustafa Ihsan;
Koksal, Aydin Seref

Publication type:

Article

Cutaneous Stevens Johnson – Toxic Epidermal Necrolysis Immunotherapy related Toxicities in Lung Cancer Patients.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1276, doi. 10.1177/10781552221074623

By:

Alexandris, Dimitrios;
Alevizopoulos, Nektarios;
Gakiopoulou, Harikleia;
Stavrinou, Nikolina;
Vourlakou, Christine

Publication type:

Article

Potential negative pharmacodynamic interaction of spironolactone and abiraterone in two prostate cancer patients.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1259, doi. 10.1177/10781552221074621

By:

Vicente-Valor, Juan;
Escudero-Vilaplana, Vicente;
Collado-Borrell, Roberto;
López-López, Cristina;
Villanueva-Bueno, Cristina;
Revuelta-Herrero, José Luis;
Ruiz-Briones, Paula;
Somoza-Fernández, Beatriz;
Herranz, Ana;
Sanjurjo, María

Publication type:

Article

Use of enfortumab vedotin in an HIV-positive patient with urothelial carcinoma.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1226, doi. 10.1177/10781552221074309

By:

Azizi, Armon;
Houshyar, Roozbeh;
Mar, Nataliya

Publication type:

Article

Role of Ketamine and Opioid Rotation in the Management of Opioid Induced Hyperalgesia in a Patient With Acute Promyelocytic Leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1254, doi. 10.1177/10781552221074285

By:

Hino, Christopher;
Ran-Castillo, Dan;
Akhtari, Mojtaba;
Cao, Huynh;
Silvestre, Julio

Publication type:

Article

Progressive Multifocal Leukoencephalopathy Among Ibrutinib Treatment In Chronic Lymphocytic Leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1249, doi. 10.1177/10781552221074281

By:

Çetintepe, Tuğba;
Gediz, Füsun;
Akyar, Işın;
Çetintepe, Lutfi;
Koç, Ali Murat

Publication type:

Article

Complete response following treatment of plasma cell leukemia with venetoclax and dexamethasone: A case report.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1244, doi. 10.1177/10781552221074269

By:

Vo, Kim;
Guan, Tiffany;
Banerjee, Rahul;
Lo, Mimi;
Young, Rebecca;
Shah, Nina

Publication type:

Article

Facial Edema Associated with Dasatinib: Case Report with Successful Treatment.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1211, doi. 10.1177/10781552221074050

By:

Nyckowski, Timothy;
Ambur, Austin;
Vinokurov, Alisa;
Nathoo, Rajiv

Publication type:

Article

A case of severe vasculitis after FLOT chemotherapy in a patient with metastatic gastric cancer who received multiple line chemotherapy.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1222, doi. 10.1177/10781552221074046

By:

Hendem, Engin;
Korkmaz, Mustafa;
Uğraklı, Muzaffer;
Karakurt Eryılmaz, Melek;
Karaağaç, Mustafa;
Araz, Murat;
Artaç, Mehmet

Publication type:

Article

Development of Monoclonal B-cell Lymphocytosis Shortly After Treatment with Nivolumab and Subsequent Progression to Chronic Lymphocytic Leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1218, doi. 10.1177/10781552221074025

By:

Jamali, Arsia;
Nemovi, Khashayar;
Kaur, Jaspreet;
Dasanu, Constantin A

Publication type:

Article

Vincristine induced fever in a child with embryonal rhadbomyosarcoma.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1209, doi. 10.1177/10781552221074015

By:

Janani, Dr. Arul;
Shruthilaya, Dr. Anandkumar;
Dhaarani, Dr. Jayaraman;
Julius, Dr. Scott X

Publication type:

Article

Pro-BNP in the differential diagnosis of dyspnea in patients treated with immune-checkpoint inhibitors: Case Report.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1239, doi. 10.1177/10781552221074007

By:

Baranseh, Jalal;
Ouryvaev, Anton;
Moady, Gassan;
Shai, Ayelet

Publication type:

Article

Panitumumab Associated Acute Pancreatitis.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1207, doi. 10.1177/10781552221073997

By:

Arbag, Huseyin Can;
Sumbul, Hilmi Erdem;
Buyuksimsek, Mahmut;
Ogul, Ali;
Yetisir, Abdullah Evren;
Koseci, Tolga;
Bozkurt Duman, Berna;
Tohumcuoglu, Mert;
Kesen, Oguzhan;
Cil, Timucin

Publication type:

Article

Three Cases of Lenalidomide Therapy for Multiple Myeloma and Subsequent Development of Secondary B-ALL.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1214, doi. 10.1177/10781552211073967

By:

Vusqa, Urwat Til;
Chahine, Zena;
Asawa, Palash;
Sadashiv, Santhosh;
Samhouri, Yazan;
Lister, John

Publication type:

Article

Multiple rechallenges with anti-PD-1 immunotherapy in patients with checkpoint inhibitor-related pneumonitis: A report of two cases.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1234, doi. 10.1177/10781552211073962

By:

Yan, Zheng;
Yao, Shuna;
Yuan, Junhui;
Liu, Yanyan;
Yao, Zhihua

Publication type:

Article

Cytogenetic guided therapy using blinatumomab and inotuzumab ozogamicin in a patient with relapse/refractory acute lymphoblastic leukemia.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1269, doi. 10.1177/10781552211073958

By:

Ohana, Zahava;
Serraes, Samantha;
Elder, Christopher;
Katusa, Nikolina

Publication type:

Article

Comparative Assessment of Platinum Salts and Taxane Group Hypersensitivity Reactions, The Role of Skin Tests in Diagnosis?

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1111, doi. 10.1177/10781552211050084

By:

Terzioğlu, Kadriye;
Ayhan, Murat

Publication type:

Article

Evaluation of the management of PARP inhibitor toxicities in ovarian and endometrial cancer within a multi-institution health-system.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1102, doi. 10.1177/10781552211024728

By:

Hatch, Rachel V;
Patel, Sweta U;
Cambareri, Christine;
Uritsky, Tanya;
Martin, Lainie P

Publication type:

Article

Drug- and patient-related factors are the strongest predictors of endocrine therapy adherence in breast cancer patients.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1070, doi. 10.1177/10781552211020805

By:

Haji-Hersi, Mariam F;
Tilley, Sophia;
Shelton, Caleb A;
Lamb, Nathan;
Kamdem, Landry K

Publication type:

Article

A real world analysis of first line treatment of advanced EGFR mutated non-small cell lung cancer: A multi-center, retrospective study.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1140, doi. 10.1177/10781552211020798

By:

Lee, Chung-Shien;
Ahmed, Iman;
Miao, Emily;
Chung, Shirley;
Patel, Khilna;
Kohn, Nina;
Seetharamu, Nagashree

Publication type:

Article

The effect of a Clinical Decision Support System on the frequency of dose adjustments of anticancer drugs in case of renal or hepatic dysfunction.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1063, doi. 10.1177/10781552211019453

By:

Rolvink, José;
Gerards, Anne-Loes E;
Kater, Arnon P;
Swart, Eleonora L;
Becker, Matthijs L

Publication type:

Article

Oncology boot camp: A preparatory curriculum for advanced pharmacy practice experience students.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1056, doi. 10.1177/10781552211019116

By:

Horn, Bethannee;
Wells, Lyn;
Halford, Zachery

Publication type:

Article

Lonsurf (trifluridine/tipiracil): Assessing the impact of dose related toxicities and progression free survival in (refractory) metastatic colorectal cancer.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1085, doi. 10.1177/10781552211017973

By:

Court, Olivia R;
Shemilt, Katherine

Publication type:

Article

Analysis of the interventions in antineoplastic therapy by a clinical pharmacy service at a tertiary hospital in Brazil.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1049, doi. 10.1177/10781552211017650

By:

da Rocha, Camile;
Carlotto, Juliane;
Zanis Neto, Jose

Publication type:

Article

RETRACTED: Adherence to treatment with oral antineoplastic therapy in outpatients.

Published in:

2022

By:

Silva, Tamires B;
Silva, Antonio TA;
Macedo, Rodrigo S;
Crozatti, Márcia TL

Publication type:

Correction Notice

MTHFR 677T-1298C haplotype in acute lymphoblastic leukemia: Impact on methotrexate therapy.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1031, doi. 10.1177/10781552211017193

By:

Frikha, Rim;
Elloumi, Moez;
Rebai, Tarek;
Kamoun, Hassen

Publication type:

Article

Retrospective analysis of mortality within 30 days of systemic anticancer therapy and comparison with a previous audit at an Australian Regional Cancer Centre.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1077, doi. 10.1177/10781552211016086

By:

Zimbwa, Bernadatte;
Gilbar, Peter J;
Davis, Mark R;
Kondalsamy-Chennakesavan, Srinivas

Publication type:

Article

Stability study of concentrate-solvent mixture & infusion solutions of Jevtana® cabazitaxel for extended multi-dosing.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1035, doi. 10.1177/10781552211016079

By:

Hedvig Arnamo, A;
Huitema, Alwin D.R;
Beijnen, Jos H;
Nuijen, Bastiaan

Publication type:

Article

Real-world evidence for carfilzomib dosing intensity on overall survival and treatment progression in multiple myeloma patients.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1130, doi. 10.1177/10781552211015283

By:

Raje, Noopur;
Medhekar, Rohan;
Panjabi, Sumeet;
Hines, Dionne M;
Wang, Xin;
Iskander, Karim;
Welliver, Tim;
Wade, Rolin L;
Ailawadhi, Sikander

Publication type:

Article

Economic impact of implementation of an automated drug supplying and management system in a Central Chemotherapy Preparation Unit in a Moroccan hospital.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1093, doi. 10.1177/10781552211013393

By:

Baraka, Soumaya El;
Ouedraogo, Jean-Marie;
Sessouma, Abou;
Arbai, Soumaya;
Belahcen, Mohammed-Jaouad;
Rahali, Younes

Publication type:

Article

Medication adherence and persistence among patients with non-small cell lung cancer receiving tyrosine kinase inhibitors and estimation of the economic burden associated with the unused medicines.

Published in:

Journal of Oncology Pharmacy Practice, 2022, v. 28, n. 5, p. 1120, doi. 10.1177/10781552211012452

By:

Joret, Romain;
Matti, Nazish;
Beck, Morgane;
Michel, Bruno

Publication type:

Article